Disease / condition

Cutaneous Lupus Erythematosus clinical trials

Free access to 16 studies·6+ countries·Updated daily2 recruiting
16
Total trials
6+
Countries
10+
Sponsors
2
Recruiting
By phase
Phase 26
N/A6
Phase 12
Early Phase 11
Phase 31
By status
Completed10
Recruiting2
Terminated2
Not yet recruit...1
Suspended1
Top countries
United States of America7
Germany3
Argentina,Australia,Canada,Chile,Czech,Hungary,India,Italy,Mexico,Poland,Russian Federation,Spain,Uk1
Canada,Moldova - Republic of,United States of America1
Canada,United States of America1
Top sponsors
Gilead Sciences2
AstraZeneca1
Ben Chong1
Centre for Human D...1
Emory University1
Recent trials
Latest clinical trials for Cutaneous Lupus Erythematosus
NCT06411106Recruiting
Deep Phenotyping of Cutaneous Lupus Erythematosus
Centre for Human Drug Research...Netherlands
NCT06015737·Phase 3Not yet recr...
A Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
AstraZeneca
2020-004703-14Completed
A randomized, double-blind, placebo controlled, proof of concept study assessing the efficacy and safety of the RIPK1-inhibitor SAR443122 in patients with moderate to severe subacute or discoid/chronic cutaneous lupus erythematosus
Sanofi-Aventis Recherche & Dév...
NCT04809623·Phase 1Suspended
Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)
Gilead SciencesUnited States of America
NCT04781816·Phase 2Recruiting
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
SanofiArgentina,Australia,Canada,Chile,Czech,Hungary,India,Italy,Mexico,Poland,Russian Federation,Spain,Uk
NCT03134222·Phase 2Completed
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
Gilead SciencesCanada,United States of America
NCT01841619·Early Phase 1Completed
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
University of California, Irvi...United States of America
NCT01776190Completed
Low-dose UVA1 Radiation in Cutaneous Lupus Patients
Ben ChongUnited States of America
NCT01629784Completed
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Northwestern UniversityUnited States of America
NCT01498406·Phase 2Terminated
Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
Emory UniversityUnited States of America
NCT01470313·Phase 1Terminated
A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
PfizerCanada,Moldova - Republic of,United States of America
NCT01300208·Phase 2Completed
To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
AmgenUnited States of America
NCT01146444Completed
Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)
Spirig Pharma Ltd.Germany
NCT00523588·Phase 2Completed
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
University of PennsylvaniaUnited States of America
NCT00420173Completed
Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
European Society of Cutaneous ...Germany
NCT00317681·Phase 2Completed
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
Heinrich-Heine University, Due...Germany
About this record

Access comprehensive clinical trial information for Cutaneous Lupus Erythematosus through Pure Global AI's free database. This collection includes 16 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 2 trials are actively recruiting participants.

Research for Cutaneous Lupus Erythematosus is being conducted in United States of America, Germany, Argentina,Australia,Canada,Chile,Czech,Hungary,India,Italy,Mexico,Poland,Russian Federation,Spain,Uk and 3+ other countries. Leading sponsors include Gilead Sciences and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 16 clinical trials studying Cutaneous Lupus Erythematosus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 6+ countries.

Top research sponsors include Gilead Sciences, AstraZeneca, Ben Chong, among others.